Method for diagnosing efficacy of xenotypic antibody therapy

Details for Australian Patent Application No. 2001240982 (hide)

Owner AltaRex Medical Corp.

Inventors Noujaim, Antoine

Agent Shelston IP

Pub. Number AU-B-2001240982

PCT Pub. Number WO01/59452

Priority 60201868 04.05.00 US; 60181008 08.02.00 US

Filing date 8 February 2001

Wipo publication date 20 August 2001

Acceptance publication date 4 May 2006

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

20 May 2004 Assignment before Grant

  Altarex Corp. The application has been assigned to AltaRex Medical Corp.

4 May 2006 Application Accepted

  Published as AU-B-2001240982

31 August 2006 Standard Patent Sealed

4 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001240983

2001240980